ArticleTherapeutic advances in medical oncology2025
Depression and anxiety in patients with breast cancer receiving radiotherapy: a longitudinal study.
Article in Therapeutic advances in medical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Prevalence and Influencing Factors of Anxiety and Depression in Patients With Breast Cancer: A Meta-Analysis.Actas espanolas de psiquiatria · 2026Pooled it
- The Role of Emotional Entitlement, Gratitude, and Social Support in Psychological Adjustment During Radiotherapy: A Longitudinal Study.Stress and health : journal of the International Society for the Investigation of Stress · 2026Article
- Integrated Chinese and Western Medicine for Breast Cancer Patients with Depression-Association with Survival and Healthcare Utilization: A Nationwide Retrospective Cohort Study in Taiwan.Healthcare (Basel, Switzerland) · 2026Article
- PSYCHOSOCIAL DISTRESS, BODY IMAGE PERCEPTION, AND COPING MECHANISMS AMONG BREAST CANCER PATIENTS: A CROSS-SECTIONAL STUDY AT A TERTIARY HEALTH FACILITY IN SUB-SAHARAN AFRICA.Annals of Ibadan postgraduate medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depression and anxiety are common among patients with breast cancer, but prospective studies of depression and anxiety after radiotherapy (RT) among these patients remain scarce. Objective: To evaluate the prevalence of and changes in depression and anxiety among patients with breast cancer from the first day of RT (T0) to 6 months post-RT, and to identify risk factors associated with depression and anxiety and higher levels of them over time. Design: This observational study used a prospective, longitudinal design. Methods: This study was conducted in China between August 2022 and August 2023. Depression and anxiety were measured, respectively, by Patient Health Questionnaire and the Generalized Anxiety Disorder Scale, from T0 to 6 months post-RT. Univariate and multivariate logistic regressions were performed to explore risk factors for baseline depression and anxiety. Generalized Estimating Equations were performed to evaluate changes in depression and anxiety and risk factors for higher levels of them over time. Results: A total of 504 patients completed baseline questionnaires (response rate: 90.9%). The prevalence of depression and anxiety decreased significantly over time, from 37.3% and 26.0% at T0, to 28.4% and 20.3% at 6 months post-RT, respectively. Having a family history of cancer and receiving anti-HER2-targeted therapy were independently associated with depression at T0, and premenopausal status, poor family income, and self-reported menopausal symptoms were independently associated with both depression and anxiety at T0. Receiving anti-HER2-targeted therapy, having a lower personal income, and living in rural areas were associated with higher depression levels over time, whereas poor family income and self-reported menopausal symptoms were associated with higher anxiety levels over time. Conclusion: Depression and anxiety levels were high among patients with breast cancer receiving RT and decreased over time from pre-RT to 6 months post-RT. Routine screening is necessary, especially for high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.